Liang Ning

ORCID: 0000-0001-9869-938X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Melanoma and MAPK Pathways
  • Cancer, Stress, Anesthesia, and Immune Response
  • Protein Kinase Regulation and GTPase Signaling
  • Myofascial pain diagnosis and treatment
  • Reproductive Biology and Fertility
  • Cardiovascular Health and Disease Prevention
  • Renal and related cancers
  • Cardiovascular Health and Risk Factors
  • Sperm and Testicular Function
  • Acupuncture Treatment Research Studies
  • Enhanced Recovery After Surgery
  • GDF15 and Related Biomarkers
  • Traditional Chinese Medicine Studies
  • Anesthesia and Neurotoxicity Research

Qingdao University
2024

Affiliated Hospital of Qingdao University
2024

Universitair Ziekenhuis Brussel
2007

Acupoint sensitization is considered an important factor in the efficacy of acupoint therapy. This study aimed to evaluate acupressure prevention stable angina pectoris using acupoints with different pressure-pain sensitivities.A total 202 patients were enrolled and randomly assigned a high-sensitivity group (HSG) (n = 109) which received at five highest sensitivity pain low-sensitivity (LSG) 93) lowest pain. The duration treatment was 4 weeks, evaluated baseline, week 4, 8. primary outcome...

10.1155/2021/7228033 article EN Evidence-based Complementary and Alternative Medicine 2021-11-02

Vemurafenib, one of the selective BRAF inhibitor, is less effective in BRAF-mutant thyroid cancer, including anaplastic cancer (ATC), mechanisms which are still lacking. Pseudopodium-enriched atypical kinase 1 (PEAK1) has been demonstrated to be upregulated human malignancies. Enhanced PEAK1 expression facilitates tumor cell survival and chemoresistance. Here we investigated role targeting reversing vemurafenib resistance ATC 8505C cells. depletion alone promotes cycle arrest, but not affect...

10.22541/au.170664058.87515636/v1 preprint EN Authorea (Authorea) 2024-01-30
Coming Soon ...